Caloric restriction for 3 and 6 months significantly attenuated the increased expression levels of ELOVL4 in the obesity group, while a significant reduction of IL-33 expression levels was observed in the obese patients with a 6-month period of caloric restriction treatment (Figure 6C). Here, ELOVL4 is linked to obesity due to melanocortin 4 receptor deficiency.